000			01652 a2200469 4500
005			20250516023919.0
264		0	_c20110715
008			201107s 0 0 spa d
022			_a1578-6749
024	7		_a10.1016/j.medin.2010.12.003 _2doi
040			_aNLM _beng _cNLM
100	1		_aSalavert, M
245	0	0	_a[Role of viral infections in immunosuppressed patients]. _h[electronic resource]
260			_bMedicina intensiva _cMar 2011
300			_a117-25 p. _bdigital
500			_aPublication Type: English Abstract; Journal Article; Review
650	0	4	_aAntibodies, Monoclonal, Murine-Derived _xtherapeutic use
650	0	4	_aAntiviral Agents _xtherapeutic use
650	0	4	_aComorbidity
650	0	4	_aCritical Care
650	0	4	_aCritical Illness
650	0	4	_aCross Infection _xdrug therapy
650	0	4	_aDisease Susceptibility
650	0	4	_aHerpesviridae Infections _xdrug therapy
650	0	4	_aHumans
650	0	4	_aImmunocompromised Host
650	0	4	_aImmunosuppressive Agents _xadverse effects
650	0	4	_aLymphoproliferative Disorders _xdrug therapy
650	0	4	_aOpportunistic Infections _xdrug therapy
650	0	4	_aPostoperative Complications _xdrug therapy
650	0	4	_aRisk Factors
650	0	4	_aRituximab
650	0	4	_aTransplantation
650	0	4	_aTumor Virus Infections _xdrug therapy
650	0	4	_aVirus Diseases _xdrug therapy
650	0	4	_aVirus Latency
700	1		_aGranada, R
700	1		_aDíaz, A
700	1		_aZaragoza, R
773	0		_tMedicina intensiva _gvol. 35 _gno. 2 _gp. 117-25
856	4	0	_uhttps://doi.org/10.1016/j.medin.2010.12.003 _zAvailable from publisher's website
999			_c20601606 _d20601606